Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hormonal Regulation

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.

Antihypertensive Drugs: Direct Renin Inhibitors

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...

Renal Corpuscle

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

Antihypertensive Drugs: Action of β1 Blockers

Antihypertensive Drugs: Action of β₁ Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Overview of clinical pharmacy activities in geriatric oncology: A systematic review.

Journal of geriatric oncology·2026

Same author

Effectiveness of long-term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease.

European journal of haematology·2022

Same author

(Pro)renin Receptor Inhibition Reduces Plasma Cholesterol and Triglycerides but Does Not Attenuate Atherosclerosis in Atherosclerotic Mice.

Frontiers in cardiovascular medicine·2022

Same author

The (pro)renin receptor (ATP6ap2) facilitates receptor-mediated endocytosis and lysosomal function in the renal proximal tubule.

Pflugers Archiv : European journal of physiology·2021

Same author

Effectiveness and safety of hFVIII/VWF concentrate (Voncento<sup>®</sup>) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational study.

Blood transfusion = Trasfusione del sangue·2020

Same author

<i>Atp6ap2</i> deletion causes extensive vacuolation that consumes the insulin content of pancreatic β cells.

Proceedings of the National Academy of Sciences of the United States of America·2019

Same journal

[Food safety of GMOs].

Journal de la Societe de biologie·2010

Same journal

[Placing on the market, breeders rights and growing genetically modified (GM) varieties].

Journal de la Societe de biologie·2010

Same journal

[Cultivation and environmental impacts of GMO crops].

Journal de la Societe de biologie·2010

Same journal

[Applications of genetically modified animals].

Journal de la Societe de biologie·2010

Same journal

[Why GMOs].

Journal de la Societe de biologie·2010

Same journal

[Mutations in renin-angiotensin system genes and kidney developmental anomalies].

Journal de la Societe de biologie·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

[The prorenin receptor].

Diane Bracquart¹, Christelle Cousin, Aurélie Contrepas

¹INSERM Unité 833, Collège de France, 11 place Marcelin Berthelot, 75005 Paris, France. diane.bracquart@college-de-france.fr

Journal De La Societe De Biologie

|February 4, 2010

Summary

This summary is machine-generated.

The novel (pro)renin receptor [(P)RR] activates signaling pathways and upregulates profibrotic genes. Targeting (P)RR offers a new strategy for optimizing renin-angiotensin system blockade in diseases.

More Related Videos

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Related Experiment Videos

Last Updated: Jun 16, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Area of Science:

Physiology and Pathology
Molecular Biology
Pharmacology

Context:

The renin-angiotensin system (RAS) plays a critical role in physiological and pathological processes.
The (pro)renin receptor [(P)RR] is a newly identified component of the RAS.
Existing RAS inhibitors are used for hypertension and organ damage, but tissue-specific blockade needs optimization.

Purpose:

To highlight the significance of the (pro)renin receptor [(P)RR] as a potential therapeutic target.
To explain the mechanisms by which (P)RR influences cellular signaling and gene expression.
To underscore the renewed interest in RAS blockers for improved therapeutic strategies.

Summary:

Binding of renin and prorenin to (P)RR activates the mitogen-activated protein kinase p42/p44 pathway.
This activation leads to the upregulation of profibrotic gene expression.
(P)RR also renders bound prorenin catalytically active, suggesting a dual role in RAS signaling.

Impact:

The (P)RR represents a promising new therapeutic target within the renin-angiotensin system.
Understanding (P)RR function may lead to novel drug development for conditions involving RAS dysregulation.
Optimizing RAS blockade through (P)RR targeting could improve treatment outcomes for hypertension and organ damage.